From: Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study
Location
Treatment group
NAC
NACRT
Overall relapse (present), n (%)
4 (15%)
7 (25%)
Local relapse (present), n (%)
2 (7.4%)
2 (7.1%)
Distant relapse (pulmonary and liver), n (%)
5 (18%)